Literature DB >> 23329065

Effects of dopamine D2 agonist quinpirole on neuronal activity of anterior cingulate cortex and striatum in rats.

Jian-Jia Huang1, Chen-Tung Yen, Tzu-Lan Liu, Hen-Wai Tsao, Ju-Wei Hsu, Meng-Li Tsai.   

Abstract

RATIONALE: The influence of acute D2 agonist quinpirole on locomotor activity has been effectively characterized. However, few studies have addressed the dynamic changes in neuronal activity of the anterior cingulate cortex (ACC) and striatum (STR), two crucial regions for cognitive and motor functions, after quinpirole administration.
OBJECTIVE: This study was conducted in order to acquire detailed information on the evoked activity of the neurons in the ACC and STR after acute quinpirole administration.
METHODS: Multichannel electrophysiological recording was used for tracking neuronal activity in the ACC and STR of urethane-anesthetized rats after administration of saline or 0.05 or 0.5 mg/kg quinpirole.
RESULTS: In contrast to the responses to saline, quinpirole dose-dependently increased the ratio of neurons, the activity of which was inhibited in the ACC and STR. By examining the ensemble neuronal activities of inhibition-responded neurons, there was no significant activity difference among the "treatments" (saline and low- and high-dose quinpirole), the "periods" (the duration of 0-15 and 16-45 min after i.v. injection), and the interaction between "treatments" and "periods." Regarding activation-responded neurons, however, there was a significant "periods" difference in both ACC and STR, and the activity of 16-45 min was significantly higher than the activity of 0-15 min after high-dose quinpirole administration in ACC (p < 0.05) and STR (p < 0.001).
CONCLUSION: Dose-dependent ACC and STR neuronal responses to quinpirole may offer a possible mechanism for understanding the locomotor responses to quinpirole in behaving rats. The late excitatory effect of high-dose quinpirole in the STR further suggests that this region would be critical for the activation of locomotor activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23329065     DOI: 10.1007/s00213-013-2965-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Differences in quinpirole-induced local cerebral glucose utilization between naive and sensitized rats.

Authors:  Toni L Carpenter; Thomas L Pazdernik; Beth Levant
Journal:  Brain Res       Date:  2003-02-28       Impact factor: 3.252

2.  Temporal and environmental effects on quinpirole-induced biphasic locomotion in rats.

Authors:  C Van Hartesveldt
Journal:  Pharmacol Biochem Behav       Date:  1997-12       Impact factor: 3.533

Review 3.  Networks related to the orbital and medial prefrontal cortex; a substrate for emotional behavior?

Authors:  J L Price; S T Carmichael; W C Drevets
Journal:  Prog Brain Res       Date:  1996       Impact factor: 2.453

4.  Afferent connections of the medial frontal cortex of the rat. II. Cortical and subcortical afferents.

Authors:  F Condé; E Maire-Lepoivre; E Audinat; F Crépel
Journal:  J Comp Neurol       Date:  1995-02-20       Impact factor: 3.215

5.  Potentiation of inhibition by general anaesthetics in neurones of the olfactory cortex in vitro.

Authors:  C N Scholfield
Journal:  Pflugers Arch       Date:  1980-02       Impact factor: 3.657

6.  Differential effects of quinpirole in the nucleus accumbens depending on the initial level of locomotor activity.

Authors:  M Wu; S M Brudzynski; G J Mogenson
Journal:  Brain Res Bull       Date:  1993       Impact factor: 4.077

7.  Unit activity in the supraoptic and paraventricular nuclei--the effects of anaesthetics.

Authors:  R E Dyball; C I McPhail
Journal:  Brain Res       Date:  1974-02-15       Impact factor: 3.252

8.  A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats.

Authors:  K E Culver; J M Rosenfeld; H Szechtman
Journal:  Psychopharmacology (Berl)       Date:  2000-08       Impact factor: 4.530

9.  Time-dependent actions of D2 family agonist quinpirole on spontaneous behavior in the rat: dissociation between sniffing and locomotion.

Authors:  J C Horvitz; G Williams; R Joy
Journal:  Psychopharmacology (Berl)       Date:  2001-04       Impact factor: 4.530

10.  Differential DAergic Control of D1 and D2 Receptor Agonist Over Locomotor Activity and GABA Level in the Striatum.

Authors:  Eun-Yee Jung; Insop Shim
Journal:  Exp Neurobiol       Date:  2011-09-20       Impact factor: 3.261

View more
  5 in total

1.  Granger causality-based synaptic weights estimation for analyzing neuronal networks.

Authors:  Pei-Chiang Shao; Jian-Jia Huang; Wei-Chang Shann; Chen-Tung Yen; Meng-Li Tsai; Chien-Chang Yen
Journal:  J Comput Neurosci       Date:  2015-03-13       Impact factor: 1.621

2.  Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia.

Authors:  Karen L Eskow Jaunarajs; Mariangela Scarduzio; Michelle E Ehrlich; Lori L McMahon; David G Standaert
Journal:  J Neurosci       Date:  2019-07-18       Impact factor: 6.167

3.  Laboratory-induced learned helplessness attenuates approach motivation as indexed by posterior versus frontal theta activity.

Authors:  Samantha J Reznik; Robin Nusslock; Narun Pornpattananangkul; Lyn Y Abramson; James A Coan; Eddie Harmon-Jones
Journal:  Cogn Affect Behav Neurosci       Date:  2017-08       Impact factor: 3.282

4.  Posterior versus frontal theta activity indexes approach motivation during affective autobiographical memories.

Authors:  K Walden; N Pornpattananangkul; A Curlee; D P McAdams; R Nusslock
Journal:  Cogn Affect Behav Neurosci       Date:  2015-03       Impact factor: 3.282

5.  Quinpirole-Mediated Regulation of Dopamine D2 Receptors Inhibits Glial Cell-Induced Neuroinflammation in Cortex and Striatum after Brain Injury.

Authors:  Sayed Ibrar Alam; Min Gi Jo; Tae Ju Park; Rahat Ullah; Sareer Ahmad; Shafiq Ur Rehman; Myeong Ok Kim
Journal:  Biomedicines       Date:  2021-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.